Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Infection and Cancer: Bi-Directorial Interactions [[electronic resource] /] / edited by Michael R. Shurin, Yasmin Thanavala, Nahed Ismail
| Infection and Cancer: Bi-Directorial Interactions [[electronic resource] /] / edited by Michael R. Shurin, Yasmin Thanavala, Nahed Ismail |
| Edizione | [1st ed. 2015.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2015 |
| Descrizione fisica | 1 online resource (400 p.) |
| Disciplina | 610 |
| Soggetto topico |
Cancer research
Infectious diseases Immunology Microbiology Cancer Research Infectious Diseases |
| ISBN | 3-319-20669-9 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Infection and Cancer: Multi-directorial relationship -- Part I Infection-associated cancers -- Human tumor viruses: A historical perspective -- Epidemiology of virus infection and human cancer -- Bacterial infections and cancer development -- Human protozoal infections and their potential for causing neoplasms -- An update on helminths in human carcinogenesis -- Infection-associated hematological malignancies -- Multiple infections and cancer: Etiology, mechanisms and implications in cancer control -- Inflammatory mechanisms of infection-associated cancer -- Part II Infection-associated cancers: Specific examples -- Helicobacter pylori: The cancer bug -- Oral infection, carcinogenesis and cancer -- Streptococcus Bovis and colorectal cancer -- Human papillomavirus-related cancers -- Part III Cancer-associated infections -- Infectious diseases in cancer patients: An overview -- Part IV Infection and cancer: Comorbid development -- Comorbid development of infection and cancer -- Part V Infection agent-based vectors for cancer therapy -- Bacterial cancer therapy: how patients might benefit from Salmonella infections -- Development of Salmonella-based cancer vaccines -- Harnessing the host immune response to infection - BCG immunotherapy for bladder cancer -- Index. |
| Record Nr. | UNINA-9910298456403321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The Tumor Immunoenvironment [[electronic resource] /] / edited by Michael R Shurin, Viktor Umansky, Anatoli Malyguine
| The Tumor Immunoenvironment [[electronic resource] /] / edited by Michael R Shurin, Viktor Umansky, Anatoli Malyguine |
| Edizione | [1st ed. 2013.] |
| Pubbl/distr/stampa | Dordrecht : , : Springer Netherlands : , : Imprint : Springer, , 2013 |
| Descrizione fisica | 1 online resource (745 p.) |
| Disciplina |
616.99
616.994079 |
| Soggetto topico |
Cancer research
Oncology Immunology Life sciences Medicine Cancer Research Oncology Life Sciences, general Biomedicine, general |
| ISBN | 94-007-6217-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Preface -- Introduction -- Role of the immunological environment in cancer initiation, development and progression -- Part I Tumor Microenvironment and Immunoenvironment -- The metastatic microenvironment -- Tumor infiltration by immune cells: pathologic evaluation and a clinical significance -- Immunologic interpretation of cancer biology: impact on clinical outcome -- Part II Developmental Characteristics of the Tumor ImmunoEnvironment -- Development of antitumor cellular immunity -- The versatile world of inflammatory chemokines in cancer.-Inflammation, Tumor Progression, and Immune Suppression -- Pleiotropic and differential functions of IL-1a and IL-1b shape the tumor microenvironment and affect the outcome of malignancies -- Impact of obesity and aging on the tumor immunoenvironment -- Part III Tumor Escape from Immune Recognition -- MHC class I antigens and the tumor microenvironment -- Tumor-produced immune regulating factors -- Roles of signaling pathways in cancer cells and immune cells in generation of immunosuppressive tumor-associated microenvironments.- T cell malfunction in the tumor environment -- Signaling of tumor-induced immunosuppression of dendritic cells -- Tumor microenvironment may shape the function and phenotype of NK cells through the induction of split anergy and generation of regulatory NK cells -- Part IV Immune Regulators in the Tumor ImmunoEnvironment -- The role of myeloid-derived suppressor cells in cancer -- Macrophage differentiation and activation states in the tumor microenvironment -- Dendritic cells and cancer: development, dysfunction and therapeutic targets -- The role of tumor-associated neutrophils in cancer -- Mast cell modulation of the tumor microenvironment -- Regulatory T cells in patients with cancer -- Tumor-evoked regulatory B cells as important mediators of cancer escape -- Part V Tumor Escape and Cancer Immunotherapy -- Cancer immunotherapy: Overview in brief -- Programming of MDSC: New opportunities for targeted therapy -- Therapeutic targeting regulatory T cells in tumor.-ChemoImmunoModulation: Focus on myeloid regulatory cells -- Combining vaccines with therapies that render tumor cells more susceptible to immune mediated killing -- Prophylactic Cancer Vaccines -- Part VI Analyzing Immune Responses in Cancer -- Approaches to Immunologic Monitoring of Clinical Trials -- Evaluation of the tumor immunoenvironment in clinical trials -- Analysis of Myeloid-derived Suppressor Cells in Patients with Cancer -- When results of T cell immune monitoring match or do not match clinical outcomes of tumor vaccine trials - what more could and should we measure? |
| Record Nr. | UNINA-9910437855403321 |
| Dordrecht : , : Springer Netherlands : , : Imprint : Springer, , 2013 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||